TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Sept. 9 NCAB Meeting: Varmus: Expect Another CR For Funding The NIH Through Mid-December September 19, 2014
TCL Archive Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured June 16, 1989
